Can Herceptin cure cancer?

Herceptin (chemical name: trastuzumab) can be used to treat HER2-positive breast cancer that is either early-stage or advanced-stage/metastatic. Herceptin is currently approved by the U.S. Food and Drug Administration: to treat metastatic HER2-positive breast cancer to stop the cancer from growing.

What is the success rate of Herceptin?

At 10 years after treatment, overall survival was better in women who were treated with Herceptin: 84% of the women who received chemotherapy plus Herceptin were alive. 75.2% of the women who received chemotherapy alone were alive.

Does Herceptin prolong life?

Herceptin has proved to be effective in prolonging the lives of the 12 percent of women with breast cancer whose malignancy hasn’t spread to other organs, and whose cancer is HER2-positive. But side effects can be a problem. Sometimes less may be better when it comes to treatment for breast cancer.

Does Herceptin really work?

The research suggests that Herceptin is just as effective for women who take it for six months instead of a year, with the additional benefit of fewer side effects. If the study findings do alter the standard of care for Herceptin, it could be a game-changer for breast cancer patients, doctors, and health plans.

THIS IS IMPORTANT:  What is the treatment for invasive ductal carcinoma grade 2?

Is Herceptin better than chemotherapy?

Patients treated with Herceptin had a 33% reduced risk of death compared to those treated with chemotherapy only. Rates of severe cardiotoxicity occurred in approximately 4% of patients treated with Herceptin in the B-31 trial and approximately 3% of patients treated with Herceptin on the N9831 trial.

How many lives has Herceptin saved?

Between 2.7 million and 3 million women have been treated with Herceptin, and women with HER2-positive breast cancer now have among the highest survival rates compared with all women with breast cancer.

Is HER2 curable?

HER2-positive breast cancer is highly curable because of the availability of these HER2-targeted therapies, so we treat patients fairly aggressively upfront to reduce the risk of them experiencing a stage IV recurrence.

How long does it take for your immune system to recover after Herceptin?

After finishing chemotherapy treatment, it can take anywhere from about 21 to 28 days for your immune system to recover.

How fast does Herceptin work?

The first dose of Herceptin takes about 90 minutes. After that, it only takes about 30 minutes to get other doses of Herceptin.

Is Herceptin effective without chemo?

Disease-free survival is how long the women lived without the cancer coming back. Overall survival is how long the women lived, whether or not the cancer came back. Three-year disease-free survival rates were: 89.5% for women treated with Herceptin alone.

Do you lose hair with Herceptin?

Answer: No, hair loss is not a common side effect of trastuzumab. If you are receiving trastuzumab in combination with chemotherapy, you may experience hair loss due to the chemotherapy.

THIS IS IMPORTANT:  How do you know you have tongue cancer?

Is Herceptin a good drug?

Long-Term Results Show 1 Year of Herceptin Best for Lowering Recurrence Risk of Early-Stage, HER2-Positive Disease. Herceptin (chemical name: trastuzumab) is a targeted therapy medicine used to treat HER2-positive breast cancer.

Is it good or bad to be HER2-positive?

About 25% of breast cancers are HER2-positive. HER2-positive cancers are a mix of good and bad news. The bad news is the tumors tend to grow more aggressively than those without the HER2 receptor. The good news is that like ER/PR-positive cancers, medicines can switch the HER2 growth receptor off.